Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BIO-TECHNE (TECH) Total Current Liabilities: 2010-2025

Historic Total Current Liabilities for BIO-TECHNE (TECH) over the last 16 years, with Jun 2025 value amounting to $175.8 million.

  • BIO-TECHNE's Total Current Liabilities rose 1.70% to $144.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $144.5 million, marking a year-over-year increase of 1.70%. This contributed to the annual value of $175.8 million for FY2025, which is 10.33% up from last year.
  • According to the latest figures from FY2025, BIO-TECHNE's Total Current Liabilities is $175.8 million, which was up 10.33% from $159.4 million recorded in FY2024.
  • In the past 5 years, BIO-TECHNE's Total Current Liabilities registered a high of $176.0 million during FY2022, and its lowest value of $128.5 million during FY2023.
  • Its 3-year average for Total Current Liabilities is $154.6 million, with a median of $159.4 million in 2024.
  • Its Total Current Liabilities has fluctuated over the past 5 years, first spiked by 42.76% in 2021, then declined by 26.99% in 2023.
  • Over the past 5 years, BIO-TECHNE's Total Current Liabilities (Yearly) stood at $152.3 million in 2021, then rose by 15.59% to $176.0 million in 2022, then fell by 26.99% to $128.5 million in 2023, then grew by 24.02% to $159.4 million in 2024, then rose by 10.33% to $175.8 million in 2025.